MONVILLE MEDICAL : revenue, balance sheet and financial ratios

MONVILLE MEDICAL is a French company founded 44 years ago, specialized in the sector Vente à distance sur catalogue spécialisé. Based in EVREUX (27000), this company of category PME shows in 2023 a revenue of 2.0 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - MONVILLE MEDICAL (SIREN 324249978)
Indicator 2025 2024 2023 2022 2021 2020 2019 2018 2016
Revenue N/C N/C 2 016 926 € N/C N/C N/C N/C N/C 1 450 207 €
Net income 170 474 € 206 560 € 183 613 € 180 995 € 215 143 € 107 183 € 184 497 € 124 965 € 92 504 €
EBITDA N/C N/C 302 686 € N/C N/C N/C N/C N/C 164 047 €
Net margin N/C N/C 9.1% N/C N/C N/C N/C N/C 6.4%

Revenue and income statement

In 2025, MONVILLE MEDICAL generates positive net income of 170 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 93 k€ -> 170 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

170 474 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 11%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 62%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

10.75%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

62.424%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

21.2%

Solvency indicators evolution
MONVILLE MEDICAL

Sector positioning

Debt ratio
10.75 2025
2023
2024
2025
Q1: 0.0
Med: 7.11
Q3: 47.58
Average

In 2025, the debt ratio of MONVILLE MEDICAL (10.75) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
62.42% 2025
2023
2024
2025
Q1: 0.0%
Med: 22.75%
Q3: 56.26%
Excellent

In 2025, the financial autonomy of MONVILLE MEDICAL (62.4%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
0.28 years 2023
2023
Q1: -0.09 years
Med: 0.0 years
Q3: 0.36 years
Average

In 2023, the repayment capacity of MONVILLE MEDICAL (0.28) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 262.41. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

262.409

Liquidity indicators evolution
MONVILLE MEDICAL

Sector positioning

Liquidity ratio
262.41 2025
2023
2024
2025
Q1: 114.18
Med: 230.1
Q3: 423.6
Good -6 pts over 3 years

In 2025, the liquidity ratio of MONVILLE MEDICAL (262.41) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
0.06x 2023
2023
Q1: 0.0x
Med: 0.0x
Q3: 0.15x
Good

In 2023, the interest coverage of MONVILLE MEDICAL (0.1x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
MONVILLE MEDICAL

Positioning of MONVILLE MEDICAL in its sector

Comparison with sector Vente à distance sur catalogue spécialisé

Valuation estimate

Based on 121 transactions of similar company sales (all years), the value of MONVILLE MEDICAL is estimated at 640 563 € (range 208 987€ - 1 729 486€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
121 transactions
208k€ 640k€ 1729k€
640 563 € Range: 208 987€ - 1 729 486€
NAF 5 all-time

Valuation method used

Net Income Multiple
170 474 € × 3.8x = 640 564 €
Range: 208 987€ - 1 729 487€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 121 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Vente à distance sur catalogue spécialisé)

Compare MONVILLE MEDICAL with other companies in the same sector:

Frequently asked questions about MONVILLE MEDICAL

What is the revenue of MONVILLE MEDICAL ?

The revenue of MONVILLE MEDICAL in 2023 is 2.0 M€.

Is MONVILLE MEDICAL profitable?

Yes, MONVILLE MEDICAL generated a net profit of 170 k€ in 2025.

Where is the headquarters of MONVILLE MEDICAL ?

The headquarters of MONVILLE MEDICAL is located in EVREUX (27000), in the department Eure.

Where to find the tax return of MONVILLE MEDICAL ?

The tax return of MONVILLE MEDICAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does MONVILLE MEDICAL operate?

MONVILLE MEDICAL operates in the sector Vente à distance sur catalogue spécialisé (NAF code 47.91B). See the 'Sector positioning' section above to compare the company with its competitors.